Table 1 Demographic Characteristics of the Study Population
|  | Edema-dominant NEL Group (n = 41) | Tumor-dominant NEL Group (n = 45) | P |
|---|---|---|---|
Age, years, median (range) | 59 (31–81) | 57 (31–77) | .362 |
No. of women patients (% of patients) | 15 (36.6%) | 22 (48.9%) | .253 |
KPS at baseline ≥70 (% of patients) | 38 (92.7%) | 40 (88.9%) | .548 |
MGMT promoter methylation (positive/negative/missing) | 18/19/4 | 16/19/10 | .285 |
Type of surgery (biopsy/STR/GTR) | 0/4/37 | 3/12/30 | .023 |
No. with pseudoprogression (% of patients) | 21 (51.2%) | 13 (28.9%) | .036 |
No. with true progression (% of patients) | 20 (48.8%) | 32 (71.1%) | .119 |
Median TTP, days | 257 (95% CI: 205.9–305.5) | 105 (95% CI: 98.5–153.6) | .042 |